Nasdaq:AKBAPublished
Akebia Therapeutic’s Vafseo® (vadadustat) Granted Additional Patent
New patent with term until 2043 further strengthens patent portfolio WALTHAM, Mass., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc.
Press releases distributed to the journalists who cover the beat — through HARO's network of 75,000+ reporters and national wire syndication.
Write it, pick a category and the moment it crosses the wire, and reach the reporters already covering your industry. Your card is charged only when an editor approves the release.
Submit a press releaseNew patent with term until 2043 further strengthens patent portfolio WALTHAM, Mass., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc.